Alpha Teknova Inc (TKNO) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Alpha Teknova Inc   (NASDAQ: TKNO)
 

Alpha Teknova Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Alpha Teknova Inc inventory turnover ratio, the Alpha Teknova Inc 's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 4.09 in the third quarter 2026, TKNO's markets remain strong, its supply chain continue to be in a grate shape.Average processing period, for Alpha Teknova Inc 's inventories remained unchanged at 89 days, in the Sep 30 2026 quarter.

Within Healthcare sector 96 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1018 in the second quarter 2026, to 1033.

TKNO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Alpha Teknova Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TKNO Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 8.14 % -9.19 % 4.58 % 3.72 % -9.9 %
Y / Y Cost of Sales Growth 8.69 % 21.67 % 16.67 % -15.75 % -19.47 %
Inventory Turnover Ratio (TTM) 4.09 4.08 3.79 3.69 3.91
TKNO's Total Ranking # 1033 # 1018 # 671 # #
Average inventory processing period 89 90 96 99 93
Seq. Inventory Growth 8.19 % 0.54 % -2.55 % 2.02 % -9.15 %
Seq. Cost of Sales Growth 7.92 % 4.29 % 3.86 % -7.01 % 20.8 %




Inventory Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 4
Healthcare Sector # 97
Overall Market # 1033

Inventory Turnover Ratio Statistics
High Average Low
5.17 3.23 2.04
(Mar 31 2022)   (Sep 30 2023)



TKNO Company Profile >> Back to TKNO Efficiency Comparisons >> Compare TKNO Inventory Turnover Ratio to its Competitors

Financial Statements
Alpha Teknova Inc 's Inventories $ 7 Millions Visit TKNO's Balance sheet
Alpha Teknova Inc 's Cost of Revenues TTM $ 29 Millions Visit TKNO's Income Statement
What are TKNO's Sales? Visit TKNO's Sales by Segment

Other Inventory Turnover Ratios
Alpha Teknova Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TKNO's Inventory Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TKNO's Competitors
Inventory Turnover Ratio for TKNO's Suppliers
Inventory Turnover Ratio for TKNO's Customers

You may also want to know
TKNO's Sales Growth Rates TKNO's Pe Price to earnings ratio TKNO's Receivables Turnover Ratio TKNO's Stock Quote
TKNO's Net Income Growth Rates TKNO's Ps Price to Sales ratio TKNO's Sales per Employee TKNO's Asset Turnover Ratio
TKNO's Net Margin TKNO's Pb Price to Book ratio TKNO's Financial Strength Ratios TKNO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Sotera Health Company  10.25 $ 558.509  Millions$ 54  Millions
Lantheus Holdings Inc   9.76 $ 604.826  Millions$ 62  Millions
Vanda Pharmaceuticals Inc   8.70 $ 14.704  Millions$ 2  Millions
Phathom Pharmaceuticals Inc   7.76 $ 53.106  Millions$ 7  Millions
Novavax inc   7.03 $ 90.533  Millions$ 13  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions

Date modified: 2026-11-06T13:05:25+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.